- Inscrit
- 10/9/11
- Messages
- 1 954
Sorence a dit:Je viens de percuter qu’il y a Tryptaman *et* Tryptamoine qui sont nouveaux ici haha
Tryptamime et typtapine sont dans un bâteau. Tryptajine tombe à l'eau...
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Sorence a dit:Je viens de percuter qu’il y a Tryptaman *et* Tryptamoine qui sont nouveaux ici haha
Sorence a dit:Un peu la même réponse, y’a pas vraiment d’interaction dynamique mais ça peut quand même faire des trucs chelous de façon imprévisible… c’est quoi ton rapport au cannabis ? Ça te fait quels effets ? Vu que ça change énormément selon les personnes
Biquette a dit:Salut, avec l'adderall oui il y a un danger de syndrome séroto, et il me semble d'effets secondaires augmentés ainsi qu'une plus longue stim résiduelle.
Avec le 4f-mph je ne sais pas, je crois qu'il joue sur la séroto également, ça ressemble pas à un bon mélange
GENERALLY AVOID: Several case reports suggest that serotonin reuptake inhibitors may potentiate the pharmacologic response to sympathomimetic agents. The exact mechanism of interaction is unclear. In one case report, a patient experienced jitteriness, racing thoughts, stomach cramps, dry eyes, palpitations, tremors, and restlessness following a single dose of phentermine ingested approximately a week after she had discontinued fluoxetine. Because of the long half-life of fluoxetine and its metabolite, an interaction with fluoxetine is possible. Similar toxic reactions have been reported when fluoxetine was used concomitantly with amphetamine or phenylpropanolamine. Additionally, some sympathomimetic agents such as amphetamines may possess serotonergic activity and should generally not be administered with serotonin reuptake inhibitors because of the additive risk of serotonin syndrome, which is a rare but serious and potentially fatal condition thought to result from hyperstimulation of brainstem 5-HT1A and 2A receptors. The interaction was suspected in a patient treated with dexamphetamine who developed symptoms consistent with the serotonin syndrome approximately 2 weeks after the addition of venlafaxine. The medications were discontinued and the patient was given cyproheptadine for suspected serotonin syndrome, whereupon symptoms promptly resolved. A second episode occurred when dexamphetamine was subsequently resumed and citalopram added. The patient improved following cessation of citalopram on his own, and residual symptoms were successfully treated with cyproheptadine.
MANAGEMENT: In general, amphetamines and other sympathomimetic appetite suppressants should not be combined with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Close monitoring for enhanced sympathomimetic effects and possible serotonin syndrome is recommended if these agents must be used together. Symptoms of the serotonin syndrome may include mental status changes such as irritability, altered consciousness, confusion, hallucinations, and coma; autonomic dysfunction such as tachycardia, hyperthermia, diaphoresis, shivering, blood pressure lability, and mydriasis; neuromuscular abnormalities such as hyperreflexia, myoclonus, tremor, rigidity, and ataxia; and gastrointestinal symptoms such as abdominal cramping, nausea, vomiting, and diarrhea.
Sorence a dit:C’est effectivement perturbant que TripSit l’ait indiqué comme étant sans danger…
SSRI can be used with ritalin ( methylphenidate) considering associated anxiety and depression with main disorder that is ADHD , but not for very long time. It might increase the drug abuse liability of methylphenidate. Do chances of dependence is there.
So always take this two medication supervised specially by psychiatrist.
Hope it help
Biquette a dit:Mais on parle d'adderall ou de methylphénidate ?
Biquette a dit:Okay. Avec la ritaline faut s'attendre à une possible amplification des effets de l'antidep.